Yüklüyor......
MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133(+) hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway
Drug resistance is still a major obstacle for efficient treatment of hepatocellular carcinoma (HCC) during the cisplatin-based chemotherapy. Recent studies have demonstrated that CD133 positive population of cancer cells are responsible for multiple drug resistance. We are supposed to take strategie...
Kaydedildi:
| Yayımlandı: | Aging (Albany NY) |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535064/ https://ncbi.nlm.nih.gov/pubmed/31056532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.101876 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|